IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.418
NA - Nord America 1.433
EU - Europa 807
OC - Oceania 26
AF - Africa 23
SA - Sud America 17
Totale 13.724
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 9.914
US - Stati Uniti d'America 1.368
HK - Hong Kong 767
CN - Cina 608
GB - Regno Unito 221
IT - Italia 189
DE - Germania 150
FI - Finlandia 54
CA - Canada 52
IN - India 48
NL - Olanda 45
TR - Turchia 27
CZ - Repubblica Ceca 25
AU - Australia 24
FR - Francia 20
PL - Polonia 20
UA - Ucraina 18
ZA - Sudafrica 14
RU - Federazione Russa 13
ES - Italia 12
BR - Brasile 11
JP - Giappone 10
MX - Messico 10
CH - Svizzera 9
SA - Arabia Saudita 7
SE - Svezia 7
ID - Indonesia 6
BE - Belgio 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CL - Cile 4
BA - Bosnia-Erzegovina 3
IR - Iran 3
LT - Lituania 3
MA - Marocco 3
BD - Bangladesh 2
CM - Camerun 2
EE - Estonia 2
HU - Ungheria 2
IE - Irlanda 2
KR - Corea 2
KZ - Kazakistan 2
MW - Malawi 2
VN - Vietnam 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
MS - Montserrat 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TH - Thailandia 1
Totale 13.724
Salva come PNG Salva come JPEG
Città #
Hong Kong 750
Singapore 519
Ashburn 349
Boardman 264
Hefei 251
London 196
Shanghai 190
Munich 87
Rome 78
San Francisco 54
Los Angeles 52
Council Bluffs 51
West Jordan 41
Seattle 39
Toronto 37
Turku 33
Pune 32
Washington 27
Amsterdam 24
Santa Clara 24
Brno 22
Helsinki 21
Sona 20
Warsaw 19
New York 12
Central 11
Guangzhou 11
Brooklyn 10
Canberra 9
Melbourne 9
Milan 9
São Paulo 9
Montreal 8
Paris 8
Mexico City 7
Tokyo 7
Chicago 6
Frankfurt am Main 6
Haikou 6
Johannesburg 6
Redmond 6
Riyadh 6
Stockholm 6
Atlanta 5
Boston 5
Charlotte 5
Dallas 5
Jinan 5
Moscow 5
Zhengzhou 5
Ankara 4
Berlin 4
Chennai 4
Hanover 4
Manchester 4
Naples 4
Sydney 4
The Dalles 4
Beijing 3
Bologna 3
Brownsville 3
Buffalo 3
Camden 3
Chengdu 3
Delhi 3
Handan 3
Nanyang 3
Newark 3
Olomouc 3
Pamplona 3
Rabat 3
Sarajevo 3
Secaucus 3
Taranto 3
Vienna 3
Almere Stad 2
Anderlecht 2
Andover 2
Baoding 2
Bari 2
Boydton 2
Cervignano del Friuli 2
Changchun 2
Changsha 2
Charleston 2
Cinisello Balsamo 2
Cuijk 2
Douala 2
Dublin 2
Falls Church 2
Fara in Sabina 2
Ferrara di Monte Baldo 2
Foligno 2
Guiyang 2
Hangzhou 2
Ho Chi Minh City 2
Houston 2
Kharkiv 2
Kyiv 2
Las Vegas 2
Totale 3.500
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 209
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 193
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 193
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 192
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 190
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 190
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 189
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 188
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 188
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 187
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 185
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 183
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 183
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 182
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 182
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 181
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 180
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 179
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 179
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 178
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 178
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 173
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 172
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 170
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 170
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 170
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 168
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 167
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 167
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 167
Assessment of liver function by the exhaled breath-print during chronic liver disease 166
Blood glucose monitoring in the normal population: the PREDICA study 165
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 164
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 164
[Hepatocarcinoma: from epidemiology to gene therapy] 161
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 159
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 152
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 123
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 101
GH-resistance in different stages of chronic liver disease 96
Anestesia e malattie non comuni 96
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 96
Diabetes in chronic liver disease: from old concepts to new evidence 95
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 95
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 94
Enhanced portal flow velocity and volume following Iloprost treatment 93
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 91
[A 73-year-old woman with vomiting and metabolic alkalosis] 91
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 90
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 90
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 89
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 86
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 86
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 86
Anesthesia & uncommon diseases 85
Radiofrequency ablation of hepatic tissue: a new experimental animal model 85
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 83
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 83
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 82
A challenging alfa-fetoprotein in a cirrhotic patient 80
Breathprinting of liver diseases 80
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 79
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 79
[A 74-year-old woman with macrocytic anemia] 79
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 79
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 77
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 76
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 76
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 76
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 75
[A 61-year-old woman with abdominal pain and urination disorders] 75
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 75
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 75
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 75
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 73
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 73
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 72
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 72
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 70
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 69
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 69
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 67
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 66
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 65
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 62
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 60
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 59
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 57
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 56
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 54
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 51
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 45
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 43
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 42
Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates 39
Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia 38
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 32
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 31
TNF-alpha and growth hormone resistance in patients with chronic liver disease 30
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 29
Totale 11.160
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/2026227 227 0 0 0 0 0 0 0 0 0 0 0
Totale 13.796